Hisamitsu Pharmaceutical
(OTC) HTSUF
Hisamitsu Pharmaceutical Financials at a Glance
Market Cap
$2.03B
Revenue (TTM)
$159.20B
Net Income (TTM)
$19.98B
EPS (TTM)
$1.83
P/E Ratio
15.77
Dividend
$0.31
Beta (Volatility)
-0.01 (Low)
Dividend
$0.31
Beta (Volatility)
-0.01 (Low)
Price
$28.59
Volume
10
Open
$28.59
Price
$28.59
Volume
10
Open
$28.59
Previous Close
$28.59
Daily Range
$28.59 - $28.59
52-Week Range
$27.42 - $32.19
Dividend
$0.31
Beta (Volatility)
-0.01 (Low)
Price
$28.59
Volume
10
Open
$28.59
Previous Close
$28.59
Daily Range
$28.59 - $28.59
52-Week Range
$27.42 - $32.19
HTSUF News
HTSUF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Hisamitsu Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
2,799
CEO
Hirotaka Nakatomi
Website
www.hisamitsu.co.jpHeadquarters
Tosu, 841-0017, JP
HTSUF Financials
Key Financial Metrics (TTM)
Gross Margin
59%
Operating Margin
11%
Net Income Margin
13%
Return on Equity
8%
Return on Capital
6%
Return on Assets
6%
Earnings Yield
6.34%
Dividend Yield
0.01%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.03B
Shares Outstanding
70.07M
Volume
10
Short Interest
0.00%
Avg. Volume
1.883
Financials (TTM)
Gross Profit
$91.20B
Operating Income
$18.89B
EBITDA
$35.05B
Operating Cash Flow
$18.77B
Capital Expenditure
$13.77B
Free Cash Flow
$4.99B
Cash & ST Invst.
$129.12B
Total Debt
$3.86B
Hisamitsu Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$39.50B
+10.3%
Gross Profit
$23.10B
+5.1%
Gross Margin
58.48%
N/A
Market Cap
$2.03B
N/A
Market Cap/Employee
$736.54K
N/A
Employees
2,759
N/A
Net Income
$4.86B
+6.5%
EBITDA
$8.06B
+41.2%
Quarterly Fundamentals
Net Cash
$108.23B
-4.8%
Accounts Receivable
$48.44B
+8.7%
Inventory
$25.66B
+8.3%
Long Term Debt
$1.43B
-23.1%
Short Term Debt
$925.36M
-13.6%
Return on Assets
5.84%
N/A
Return on Invested Capital
6.29%
N/A
Free Cash Flow
$0.00
N/A
Operating Cash Flow
$0.00
N/A